Search Site:

Main menu:


DFCI HMS Broad

Home

The Novina lab combines basic science and advanced technologies to accelerate the translation of biological discoveries into novel therapies. Areas of focus in the lab include the role of non-coding RNAs in oncogenesis, single cell analysis of bone marrow failure syndromes, epigenetic engineering to treat ovarian cancer, and innovative approaches to tumor immunotherapy. The Novina Lab is a highly-collaborative and entrepreneurial environment. We have many clinical, technological, computational, and disease modeling collaborators who provide us with insights that help guide our research.

The Novina Lab provides a robust training environment for graduate students, postdoctoral scientists and clinical fellows. We are members of multiple communities at Dana-Farber including the Department of Cancer Immunology and Virology, the Cancer Immunotherapy Working Group, and the Center for Cancer Functional Epigenomics; at Harvard Medical School including BBS, Immunology and Virology Graduate Programs, and The Harvard Biotechnology Incubator; and at the Broad Institute of Harvard and MIT including the Cancer Program, Cell Circuits and Epigenomics Program and the Broad Technology Labs.

The following pages expand upon our approach to research, collaboration, community and mentorship.

Links related to Novina Lab research
DFCI Researcher Profile
Cancer Immunology and Virology Faculty Profile
DF/HCC Member Profile
BBS Rotation Manual Profile
Immunology Rotation Manual Profile
Office of Research and Technology Ventures
Dr. Novina’s Youtube video on epigenetic reprogramming
Dr. Novina wins the 2015 NIH Directors’ Pioneer Award
Dr. Novina’s Interviews with International Innovation in 2013 and 2014

siRNA